Kane Logo Cropped TransBG.png
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results
26 mars 2024 16h05 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial...
Kane Logo Cropped TransBG.png
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
20 mars 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announces today that it has extended the exclusivity period on...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
19 mars 2024 16h10 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
08 mars 2024 09h00 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the Bioscience Association of Manitoba...
Kane Logo Cropped TransBG.png
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
22 févr. 2024 08h00 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the shareholders...
Kane Logo Cropped TransBG.png
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
31 janv. 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Kane Logo Cropped TransBG.png
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
25 janv. 2024 12h03 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Special Meeting of Shareholders
18 janv. 2024 16h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Correction to Press Release
29 déc. 2023 14h33 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) today announces a correction to its press release dated...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Amendment to its Credit Facility
28 déc. 2023 16h05 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 20, 2023, the Company and...